Lactobacterin (Lyophilisate, Suppositories) Instructions for Use
ATC Code
A07FA01 (Lactic acid-producing microorganisms)
Active Substance
Lactobacillus (Grouping name)
Clinical-Pharmacological Group
Drug regulating the balance of intestinal microflora (probiotic)
Pharmacotherapeutic Group
Antidiarrheal, intestinal anti-inflammatory/antimicrobial agents; antidiarrheal microorganisms
Pharmacological Action
The therapeutic effect of the drug is due to the antagonistic action of lactobacilli against pathogenic and conditionally pathogenic microorganisms, including staphylococci, enteropathogenic Escherichia coli, Proteus, Shigella, which determines the corrective effect of the drug in cases of bacteriocenosis disorders.
The drug improves metabolic processes, prevents the formation of protracted forms of intestinal diseases, and increases the body’s nonspecific resistance.
Indications
For gastrointestinal diseases
- Convalescents who have had acute intestinal infections, in the presence of intestinal dysfunction or isolation of pathogenic and conditionally pathogenic bacteria;
- Somatic diseases complicated by dysbiosis resulting from the use of antibiotics, chemotherapy, and other causes;
- Complex treatment of weakened children with diseases of infectious and non-infectious etiology, accompanied by dysbiosis and atopic dermatitis;
- Chronic colitis of various etiologies, including nonspecific ulcerative colitis.
For diseases of the female genital area
- For sanitation of the genital tract in nonspecific inflammatory diseases of the genitals and for prenatal preparation of pregnant women in the “risk” group with violations of the purity of vaginal secretion up to III-IV degree.
ICD codes
| ICD-10 code | Indication |
| A03 | Shigellosis |
| A04.0 | Enteropathogenic Escherichia coli infection |
| A09 | Other and unspecified gastroenteritis and colitis of infectious origin |
| K51 | Ulcerative colitis |
| K52 | Other noninfectious gastroenteritis and colitis |
| K63 | Other diseases of intestine |
| L20.8 | Other atopic dermatitis (neurodermatitis, eczema) |
| N76 | Other inflammatory diseases of vagina and vulva |
| ICD-11 code | Indication |
| 1A02 | Intestinal infections due to Shigella |
| 1A03.0 | Infection due to enteropathogenic strains of Escherichia coli |
| 1A40.Z | Infectious gastroenteritis or colitis, unspecified |
| 9A06.70 | Atopic eczema of the eyelids |
| DA42.81 | Radiation gastritis |
| DA42.8Z | Gastritis due to external causes, unspecified |
| DA51.53 | Radiation duodenitis |
| DA51.5Z | Duodenitis due to external causes, unspecified |
| DB31.Z | Other acquired anatomical changes of the colon, unspecified |
| DB33.2Z | Allergic or alimentary colitis, unspecified |
| DB33.4Y | Other specified colitis or proctitis caused by external agents |
| DB33.4Z | Colitis or proctitis caused by external agents, unspecified |
| DD71.Z | Ulcerative colitis, unspecified |
| DE2Z | Diseases of the digestive system, unspecified |
| EA80.0 | Infantile atopic eczema |
| EA80.1 | Childhood atopic eczema |
| EA80.2 | Adult atopic eczema |
| EA80.Z | Atopic eczema, unspecified |
| EA85.20 | Atopic hand eczema |
| GA00 | Vulvitis |
| GA02.Z | Unspecified vaginitis |
| GA0Z | Inflammatory diseases of female genital tract, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Lyophilisate
Lactobacterin for intestinal diseases is used orally, and in obstetric-gynecological practice – intravaginally.
Dissolve the contents of the vial with boiled water at room temperature at the rate of 5 ml (a teaspoon) of water per 1 dose of the drug.
Dissolve as follows: pour the required amount of water into a glass (according to the number of doses indicated on the vial); open the vial by removing the cap and stopper; transfer a small amount of water from the glass into the vial; after dissolution (the drug dissolves in no more than 5 minutes, forming a homogeneous whitish-gray or yellowish-beige suspension), transfer the contents of the vial into the same glass and mix. One teaspoon of the drug dissolved in this way constitutes 1 dose.
For intestinal diseases, the drug should be taken 40-60 minutes before meals and preferably washed down with milk. Treatment is recommended to be accompanied by the use of vitamins.
For intestinal diseases, Lactobacterin is used in the following daily doses
| Age | Dose |
| Up to 6 months | 3 doses 2 times a day |
| From 6 months to 1 year | 3 doses 3 times a day |
| From 1 to 3 years | 5 doses 2 times a day |
| Over 3 years and adults | 5 doses 2-3 times a day |
The course of treatment with Lactobacterin for various diseases is
A) for protracted and chronic course of dysentery, post-dysenteric colitis, convalescent treatment after acute intestinal infections, as well as for prolonged intestinal dysfunction of unknown etiology – at least 4-6 weeks;
B) for nonspecific ulcerative colitis, as well as chronic colitis and enterocolitis – up to 2 months;
C) for dysbiosis of various etiologies – 3-4 weeks.
If there is no effect from the use of the drug for 2 weeks, it is necessary to re-examine the microflora of the gastrointestinal tract and correct it with other drugs depending on the result obtained.
To consolidate the obtained clinical effect or in the absence of complete normalization of microflora after the end of the course of treatment, for diseases occurring with relapses, repeated courses of treatment are advisable. In these cases, before prescribing the drug, a repeated examination of the microflora is necessary. Maintenance doses of the drug (half the daily dose) are prescribed after 2-3 weeks for 1-1.5 months.
For inflammatory diseases of the genitals, Lactobacterin is prescribed at 5 doses 2 times a day intravaginally for 10-12 days, starting from the 10-12th day of the menstrual cycle. For prenatal preparation of pregnant women in the “risk” group, Lactobacterin is prescribed at 5 doses once a day for 5-8 days.
For intravaginal use, dissolve the contents of the vial in 5-10 ml of boiled water at room temperature, soak a sterile tampon with the dissolved drug, insert the tampon into the vagina and leave for 2-3 hours.
Treatment should be carried out under the control of the restoration of the purity of vaginal secretion to I-II degree, the appearance of lactoflora and the disappearance of clinical symptoms of the disease.
Suppositories
Administered orally, administered intravaginally.
The dose is set individually, depending on the indication, method of application, patient’s age, treatment regimen.
In children and adolescents under 18 years of age, this agent should be used in dosage forms intended for the corresponding age group.
Adverse Reactions
Reaction to the administration of the drug has not been identified.
Contraindications
- Vulvovaginal candidiasis.
Use in Pregnancy and Lactation
Permitted.
Special Precautions
Precautions for use.
The dissolved drug must not be stored. The drug is unsuitable for use if the integrity of the packaging is compromised (cracked vials), the drug without labeling, the drug with changed physical properties (change in color, shrinkage of biomass), in the presence of foreign inclusions.
Influence on the ability to drive vehicles and mechanisms
None.
Overdose
Not registered.
Drug Interactions
Due to the high antibiotic resistance of lactobacilli, the use of Lactobacterin during antibiotic therapy is allowed.
Storage Conditions
In accordance with SP 3.3.2.1248-03 at a temperature not exceeding 10°C (50°F). Keep out of reach of children.
Shelf Life
The shelf life of the drug is 1 year (with a content of at least 2×109 live lactobacilli per dose); 2 years (with a content of at least 4×109 live lactobacilli per dose).
Dispensing Status
Over-the-counter.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Lyophilisate for preparation of suspension for oral and topical administration 2×109 CFU: fl. 3 doses or 5 doses 10 pcs.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Dosage Form
| Lactobacterin | Lyophilisate for preparation of suspension for oral and topical administration 2×109 CFU: fl. 3 doses or 5 doses 10 pcs. |
Dosage Form, Packaging, and Composition
Lyophilisate for preparation of suspension for oral and topical administration in the form of a crystalline or porous mass of yellowish-beige or whitish-gray color of varying intensity; has a specific odor.
| 1 dose | |
| Live Lactobacillus* | At least 2×109 CFU |
*represents a biomass of live bacteria of an antagonistically active strain of lactobacilli (Lactobacillus plantarum 8P-A3), lyophilized in a culture medium with the addition of a protective drying medium (sucrose-gelatin-milk).
Excipients: components of the protective drying medium** (gelatin, sucrose (sugar), milk).
3 doses – vials (10) – cardboard packs.
5 doses – vials (10) – cardboard packs.
3 doses – vials (5) – contour cell packs (2) – cardboard packs.
5 doses – vials (5) – contour cell packs (2) – cardboard packs.
**the content of the components of the protective drying medium in the finished preparation is not determined.
Vaginal suppositories 107 CFU: 10 pcs.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Dosage Form
| Lactobacterin | Vaginal suppositories 107 CFU: 10 pcs. |
Dosage Form, Packaging, and Composition
Vaginal suppositories from white to light beige, torpedo-shaped or cylindrical; heterogeneity of color in the form of inclusions or “marbling” is allowed.
| 1 supp. | |
| Live lactobacilli* | ≥107 CFU |
* represents a microbial mass of a live, antagonistically active strain of Lactobacillus plantarum 8P-A3, lyophilized in a drying medium (sucrose-gelatin-milk) and formed into a suppository.
Excipients: special purpose fat “SolPro” confectionery – 75-85%, petroleum paraffin grade P-2 – 5-10%, emulsifier “Solid – 2” (T-2) – 5-10%, components of the protective drying medium (food gelatin – 0.5-1.5%, sucrose (sugar) – 5-7%, skimmed milk or natural cow’s milk (in terms of dry matter) – 1-2.5%).
5 pcs. – non-cell contour packs (2) – cardboard packs.
Lyophilisate for the preparation of suspension for oral and topical administration 2 billion CFU: vial 3 doses or 5 doses 10 pcs.
Lyophilisate for the preparation of suspension for oral and topical administration 4 billion CFU: vial 3 doses or 5 doses 10 pcs.
Tablets 2 billion CFU: 100 or 200 pcs.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Dosage Forms
| Lactobacterin dry | Lyophilisate for the preparation of suspension for oral and topical administration 2 billion CFU: vial 3 doses or 5 doses 10 pcs. | |
| Lactobacterin dry | Lyophilisate for the preparation of suspension for oral and topical administration 4 billion CFU: vial 3 doses or 5 doses 10 pcs. | |
| Lactobacterin | Tablets 2 billion CFU: 100 or 200 pcs. |
Dosage Form, Packaging, and Composition
| Lyophilisate for preparation of suspension for oral and topical administration | 1 dose |
| Lactobacillus | 2 billion CFU |
20 pcs. – vials (5) – cardboard packs.
20 pcs. – vials (10) – cardboard packs.
| Lyophilisate for preparation of suspension for oral and topical administration | 1 dose |
| Lactobacillus | 4 billion CFU |
3 doses – vials (10) – cardboard packs.
5 doses – vials (10) – cardboard packs.
| Tablets | 1 tab. |
| Lactobacillus acidophilus | 2 billion CFU |
20 pcs. – vials (5) – cardboard packs.
20 pcs. – vials (10) – cardboard packs.
Actovegin pills 200mg, 50pcs
Ingavirin capsules 90mg, 10pcs
Daivobet, ointment, 30g
Noopept, pills 10mg, 50pcs
OKI, sachets 80mg 2g, 12pcs
Fenotropil pills 100mg, 60pcs
Picamilon pills 50mg, 60pcs
Cortexin, 10mg, 5ml, 10pcs
Kagocel pills 12mg, 30pcs
Phenibut-Vertex pills 250mg, 20pcs
Belosalic, ointment, 30g
Cavinton Comfort, dispersible pills 10mg 90pcs
Arbidol, capsules 100mg, 40pcs
Nootropil pills 800mg, 30pcs
Belosalic, lotion solution for external use spray 100ml
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Mildronate capsules 500mg, 90pcs 